Anna Zampetaki

8.0k citations
62 papers · 6.1k indexed · 1 hit paper · h-index 37
Topics
MicroRNA in disease regulation (24 papers)Cancer-related molecular mechanisms research (15 papers)Circular RNAs in diseases (14 papers)

In The Last Decade

Anna Zampetaki

60 papers receiving 6.0k citations

Hit Papers

Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR...201020262015202020102505007501000

Peers

Anna Zampetaki
Comparison fields: 5 of 128
  • Molecular Biology 4.2k
  • Cancer Research 3.0k
  • Surgery 731
  • Cardiology and Cardiovascular Medicine 584
  • Immunology 577
Replace Reinier A. Boon with:
Reinier A. Boon Germany
Qingzhong Xiao United Kingdom
Xiaoke Yin United Kingdom
Maria Felice Brizzi Italy
Gerolama Condorelli Italy
Mark W. Feinberg United States
Renhai Cao Sweden
Guy Eelen Belgium
Brian R. Wamhoff United States
Da‐Zhi Wang United States
Anna Zampetaki relative to Reinier A. Boon Germany Reinier A. Boon's profile →
Citations per field
00.5×1.5×
Reinier A. Boon · 1×
Citations per year

Countries citing papers authored by Anna Zampetaki

Since Specialization
Citations

This map shows the geographic impact of Anna Zampetaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Zampetaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Zampetaki more than expected).

Fields of papers citing papers by Anna Zampetaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Zampetaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Zampetaki. The network helps show where Anna Zampetaki may publish in the future.

Co-authorship network of co-authors of Anna Zampetaki

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Zampetaki. A scholar is included among the top collaborators of Anna Zampetaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Zampetaki. Anna Zampetaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 20
4 167
5 32
6
Abstract 19935: MicroRNA-21 Regulates Transforming Growth Factor Beta-1 Release From Platelets: A Novel Mechanism for the Anti-Fibrotic Effects of MicroRNA-21 Inhibition
1
7 35
8 21
9 32
10 36
11 95
12 73
13 0
14 68
15 106
16 232
17 40
18 36
19
Abstract 1294: XBP1 is a Key Protein Inducing Endothelial Cell Death in vivo and in vitro
1
20 49

About Anna Zampetaki

Anna Zampetaki is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 62 papers that have together received 6.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (24 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (14 papers). The work is most often cited by research in Cancer Research (3.0k citations), Molecular Biology (4.2k citations) and Immunology (577 citations). Anna Zampetaki has collaborated with scholars based in United Kingdom, United States and Austria. Frequent co-authors include Manuel Mayr, Qingbo Xu, Stefan Kiechl, Peter Willeit, Ignat Drozdov, Yanhua Hu, Johann Willeit, Marianna Prokopi, John Paul Kirton and Ajay M. Shah. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026